Neurotechnologies – status quo and development potential
PrintKehl, C.; Hommrich, D.(2026). Neurotechnologien – Stand und Entwicklungspotenziale, TA-Kompakt Nr. 8, Büro für Technikfolgen-Abschätzung beim Deutschen Bundestag (TAB).. doi:10.5445/IR/1000197624
Neurotechnologies enable the measurement, analysis and modulation of neural activity and are increasingly regarded as an innovative field of technology with growing significance for healthcare, industry and society. Advances in brain-computer interfaces, neural implants, brain stimulation and artificial intelligence have expanded the range of potential applications in recent years, accelerating the development of the field.
This TA-Kompakt study examines the current state of invasive and non-invasive neurotechnologies, their development prospects and related challenges from a technology assessment perspective. It analyses progress in key enabling technologies and reviews applications in medicine, everyday life and the military domain. In addition, the study addresses central ethical, legal and societal issues, including mental privacy, autonomy, justice, and challenges for regulation and governance.
The study finds that medical applications remain the primary driver of neurotechnological innovation and offer significant potential in areas such as Parkinson’s disease, epilepsy, stroke rehabilitation and communication support for people with severe paralysis. At the same time, non-medical applications in the consumer sector are becoming increasingly important. While Germany benefits from strong research institutions and a highly competitive medical technology sector, challenges remain in clinical translation, commercialisation and international competitiveness. Finally, the study discusses possible future development pathways and identifies key levers for strengthening innovation, clinical translation and responsible governance.
This TA-Kompakt study examines the current state of invasive and non-invasive neurotechnologies, their development prospects and related challenges from a technology assessment perspective. It analyses progress in key enabling technologies and reviews applications in medicine, everyday life and the military domain. In addition, the study addresses central ethical, legal and societal issues, including mental privacy, autonomy, justice, and challenges for regulation and governance.
The study finds that medical applications remain the primary driver of neurotechnological innovation and offer significant potential in areas such as Parkinson’s disease, epilepsy, stroke rehabilitation and communication support for people with severe paralysis. At the same time, non-medical applications in the consumer sector are becoming increasingly important. While Germany benefits from strong research institutions and a highly competitive medical technology sector, challenges remain in clinical translation, commercialisation and international competitiveness. Finally, the study discusses possible future development pathways and identifies key levers for strengthening innovation, clinical translation and responsible governance.